tradingkey.logo

STRATA Skin Sciences Inc

SSKN
1.780USD
+0.080+4.71%
Close 11/04, 16:00ETQuotes delayed by 15 min
7.42MMarket Cap
LossP/E TTM

STRATA Skin Sciences Inc

1.780
+0.080+4.71%

More Details of STRATA Skin Sciences Inc Company

STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

STRATA Skin Sciences Inc Info

Ticker SymbolSSKN
Company nameStrata Skin Sciences Inc
IPO dateOct 28, 2005
CEODr. Dolev Rafaeli
Number of employees106
Security typeOrdinary Share
Fiscal year-endOct 28
Address5 Walnut Grove Drive, Suite 140
CityHORSHAM
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code19044
Phone12156193200
Websitehttps://www.strataskinsciences.com/
Ticker SymbolSSKN
IPO dateOct 28, 2005
CEODr. Dolev Rafaeli

Company Executives of STRATA Skin Sciences Inc

Name
Name/Position
Position
Shareholding
Change
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
United States (Country)
5.06M
66.03%
China
1.66M
21.65%
Foreign
456.00K
5.95%
Middle East
307.00K
4.01%
Other foreign
181.00K
2.36%
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Nov 1
Updated: Sat, Nov 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
27.37%
22NW, LP
10.19%
Nantahala Capital Management, LLC
7.67%
Lincoln Alternative Strategies LLC
6.94%
Heights Capital Management, Inc.
6.94%
Other
40.89%
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
27.37%
22NW, LP
10.19%
Nantahala Capital Management, LLC
7.67%
Lincoln Alternative Strategies LLC
6.94%
Heights Capital Management, Inc.
6.94%
Other
40.89%
Shareholder Types
Shareholders
Proportion
Private Equity
27.37%
Investment Advisor/Hedge Fund
10.73%
Hedge Fund
9.81%
Investment Advisor
9.33%
Corporation
6.94%
Individual Investor
0.38%
Other
35.44%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
39
3.02M
57.24%
+246.62K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Accelmed Growth Partners Management Ltd
1.44M
27.37%
--
--
Sep 04, 2025
22NW, LP
537.00K
10.19%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
403.92K
7.67%
--
--
Jun 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Heights Capital Management, Inc.
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
98.03K
1.86%
-3.80K
-3.73%
Jun 30, 2025
The Vanguard Group, Inc.
84.63K
1.61%
--
--
Jun 30, 2025
Rubinstein (Samuel)
19.86K
0.38%
+18.03K
+983.47%
Mar 31, 2025
Geode Capital Management, L.L.C.
18.19K
0.35%
-76.00
-0.42%
Jun 30, 2025
MGO One Seven LLC
17.14K
0.33%
--
--
Jun 30, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
KeyAI